JAK Inhibitors for Treatment of Psoriasis: Focus on Selective TYK2 Inhibitors
Miguel Nogueira, L. Puig, Tiago Torres
Topics & Concepts
PsoriasisJanus kinaseMedicineTyrosine kinase 2TofacitinibSTAT proteinJAK-STAT signaling pathwayClinical trialPharmacologyImmunologyTyrosine kinaseInternal medicineSignal transductionCytokineReceptorSTAT3Rheumatoid arthritisBiologyGrowth factorBiochemistryPlatelet-derived growth factor receptorCytokine Signaling Pathways and InteractionsPsoriasis: Treatment and PathogenesisMast cells and histamine